12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients

NCT01843348 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

612

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation
Renal Transplantation

Interventions

DRUG: Everolimus
DRUG: Tacrolimus
DRUG: Cyclosporin A
DRUG: Enteric Coated Mycophenolate Sodium (EC-MPS)
DRUG: Mycophenolate mofetil (MMF)
DRUG: Corticosteroids
DRUG: Simulect

Sponsor

Novartis Pharmaceuticals